Warning letter
Interpharm Praha A.S.: warning letter of Oct 18, 2016
FDA warning letter 493758 · Center for Drug Evaluation and Research
Key facts
| Reference number | 493758 |
|---|---|
| Company | Interpharm Praha A.S. |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated |
| Issue date | Oct 18, 2016 |
| Posted date | Oct 25, 2016 |
| Issuing office | Center for Drug Evaluation and Research |
| Product type | Drugs |
| CFR sections cited | 211.68(b), 211.160(b) |
| Inspection city | Prague 12 |
| Inspection start date | Oct 12, 2015 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: